RT Journal Article
SR Electronic
T1 Pre-existing effector T-cell levels and augmented myeloid cell composition denote response to CDK4/6 inhibitor palbociclib and pembrolizumab in hormone receptor-positive metastatic breast cancer
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e002084
DO 10.1136/jitc-2020-002084
VO 9
IS 3
A1 Egelston, Colt
A1 Guo, Weihua
A1 Yost, Susan
A1 Lee, Jin Sun
A1 Rose, David
A1 Avalos, Christian
A1 Ye, Jian
A1 Frankel, Paul
A1 Schmolze, Daniel
A1 Waisman, James
A1 Lee, Peter
A1 Yuan, Yuan
YR 2021
UL http://jitc.bmj.com/content/9/3/e002084.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.